CHIANG MAI ALIST CLINIC
| Tailândia | Turquia | Áustria | |
| Terapia de protão | de $90,000 / 3,060,000฿ | de $70,000 / 2,380,000฿ | de $80,000 / 2,720,000฿ |
| Terapia por protões para cancro da próstata | de $45,000 / 1,530,000฿ | de $30,000 / 1,020,000฿ | de $80,000 / 2,720,000฿ |
| Terapia de protões para cancro da mama | de $50,000 / 1,700,000฿ | de $30,000 / 1,020,000฿ | de $55,000 / 1,870,000฿ |
A Bookimed não adiciona taxas extras aos preços de Terapia de protão. As tarifas vêm das listas oficiais das clínicas. O pagamento é feito diretamente na clínica na chegada.
A Bookimed está comprometida com sua segurança. Trabalha apenas com instituições que mantêm altos padrões internacionais em Terapia de protão e têm as licenças necessárias para atender pacientes internacionais em todo o mundo.
A Bookimed oferece assistência gratuita de especialistas. Um coordenador médico pessoal apoia antes, durante e após o tratamento, solucionando problemas. Nunca está sozinho em sua jornada de Terapia de protão.
Patients can receive proton-beam therapy in Bangkok at the HRH Princess Maha Chakri Sirindhorn Proton Center (HPSP) and the Oxyion Proton Therapy Center. These facilities specialize in treating complex pediatric, spinal, and prostate cancers using high-precision radiation that spares healthy surrounding tissues.
Bookimed Expert Insight: While Thailand offers world-class medical tourism, proton therapy is centralized in Bangkok. Patients should choose clinics like those partnered with Bumrungrad for streamlined logistics. These centers manage the 4-8 week stay required for full treatment cycles efficiently.
Patient Consensus: International patients highlight significant savings and efficient 20-minute treatment sessions. They recommend securing a medical visa extension early for the multi-week recovery period.
Proton-beam therapy in Thailand demonstrates high success, with five-year survival rates for pediatric patients reaching 80% to 90%. Specialized centers report local control rates between 90.8% for early-stage lung cancer and 95% for low-risk prostate cases, matching top-tier international clinical benchmarks.
Bookimed Expert Insight: Thailand's high success rates stem from the concentration of advanced technology in select academic centers. The Her Royal Highness Princess Maha Chakri Sirindhorn Proton Center was the first in Southeast Asia. This early adoption means Thai radiation oncologists have managed complex cases longer than most regional peers.
Patient Consensus: Many patients emphasize that 90% biochemical control for prostate cancer aligns with global standards. They highlight the importance of following strict imaging schedules to maintain these high success figures.
Proton-beam therapy is best suited for localized solid tumors situated near critical organs or sensitive structures. This precision treatment is the gold standard for pediatric cancers, skull-base tumors, and ocular melanomas where sparing surrounding healthy tissue is vital for preserving life-sustaining functions.
Bookimed Expert Insight: While proton therapy is highly advanced, it is not a universal solution for all stages. Data shows it is most effective for stationary, localized targets rather than widespread metastases. Patients seeking treatment in Thailand can access this technology at approximately 1/3 the cost of US facilities while receiving care from English-speaking specialists at top-tier centers.
Patient Consensus: Many families choose this for pediatric cases to avoid long-term growth issues. Patients with prostate or eye cancers frequently report high satisfaction due to the significant reduction in life-altering side effects.
Thai government insurance schemes like the Universal Coverage Scheme (UCS) and Civil Servant Medical Benefit Scheme (CSMBS) cover proton-beam therapy under strict clinical necessity. Eligibility primarily includes pediatric patients under 15 and adults where conventional radiation poses high risks to healthy tissue.
Bookimed Expert Insight: While government schemes offer a vital safety net, the strict criteria mean many patients seek private options. Private facilities like Wattanosoth Cancer Hospital are expanding capacity, but expect out-of-pocket costs to reach $90,000 or higher. Comparing these costs to Singapore or South Korea can reveal more immediate treatment availability.
Patient Consensus: Many patients find navigating the strict NHSO requirements challenging and often feel standard radiation is the only accessible option. Those pursuing proton therapy frequently prepare for significant out-of-pocket expenses or explore employer-sponsored plans for better access.
Thailand currently hosts one operational proton therapy facility, the Her Royal Highness Princess Maha Chakri Sirindhorn Proton Center (HPSP) in Bangkok. It utilizes the Varian ProBeam Compact system, featuring pencil-beam scanning technology and a 360-degree rotating gantry to target complex tumors in both children and adults.
Bookimed Expert Insight: While HPSP is the primary public provider, high demand often leads to waitlists. Some Thai hospitals like Samitivej Sukhumvit maintain international referral partnerships. These programs provide seamless access to cyclotron-based systems in nearby regional hubs. This reflects a growing network beyond a single physical location.
Patient Consensus: Patients report that treatment sessions are efficient, often lasting only 15-20 minutes. Many emphasize the importance of English-speaking physicists for clear communication during the planning phase.